Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring
- Luke R Bereznicki1,
- Shane L Jackson1,
- Gregory M Peterson1,
- Ella C Jeffrey1,
- Katherine A Marsden2,
- David M Jupe2
- 1Unit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania, Hobart, Australia
- 2Department of Haematology, Royal Hobart Hospital, Hobart, Australia
- Correspondence to: MrL R Bereznicki Unit for Medication Outcomes Research and Education, Tasmanian School of Pharmacy, Private Bag 83 Hobart, Hobart Tasmania, Hobart 7001, Australia; Luke.Bereznicki{at}utas.edu.au
- Accepted 25 March 2006
- Published Online First 2 June 2006
Abstract
Aim: To evaluate the accuracy of the CoaguChek XS international normalised ratio (INR) monitor compared with the laboratory method.
Methods: The accuracy and ease of use of the recently marketed CoaguChek XS portable INR monitor was evaluated in 17 patients involved in a trial of warfarin home monitoring. INR results from the monitor were compared with those from the laboratory method. Clinical applicability was measured by discrepant INR values, defined in the literature by expanded and narrow agreement criteria, and by the proportion of INR values differing by >15% and by >20% from those derived by the laboratory method.
Results: Participants provided 59 comparison INR measurements for analysis. The paired results were highly correlated (r = 0.91). Expanded and narrow agreement between paired INR values occurred 100% of the time. Only three CoaguChek XS (5.1%) results differed by >15% compared with the laboratory method; no results differed by >20% or were discrepant by >0.5 INR units.
Conclusions: In the hands of patients the CoaguChek XS showed good correlation with laboratory determination of INR and compared well with expanded and narrow clinical agreement criteria. Both patients and doctors were highly satisfied with the accuracy and ease of use of the CoaguChek XS.
Footnotes
-
Published Online First 2 June 2006
-
We thank Roche Diagnostics Australia and Neuragenix Pty Ltd for their assistance with this project. This project was supported by the Tasmanian Electronic Commerce Centre under the Business Development Fund, an element of the Launceston Broadband Project, funded by the Commonwealth through the Department of Communications, Information Technology and the Arts.
-
Competing interests: None.
-
LRB is the recipient of a National Institute of Clinical Studies Scholarship and SLJ is a National Institute of Clinical Studies Fellow.
